Murata Vios, Inc. recalls muRata Vios Monitoring System Model 2050; bedside cardiac monitor
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.
- Products
-
- muRata Vios Monitoring System Model 2050; bedside cardiac monitor
- Company
- Murata Vios, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of NY, TX, OH, MD and the country of India.
States: Maryland, New York, Ohio, Texas
- Units affected
- 62 units
- About this recall
- muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate